Role of Interferon Regulatory Factor-1 in the Induction of Biliary Glycoprotein (Cell CAM-1) by Interferon-γ*

  1. Charng-Jui Chen,
  2. Tsiu-Ti Lin and
  3. John E. Shively
  1. From the Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010
  1. To whom correspondence and reprint requests should be addressed. Tel.: 818-359-8111 (ext. 2601); Fax: 818-301-8186.

Abstract

Biliary glycoprotein (BGP), also known as C-CAM-1, has been shown to be down-regulated in colon and prostate tumors. Previously, we demonstrated that BGP mRNA is up-regulated by interferon-γ (IFN-γ) in colon cancer cell lines (Takahashi, H., Okai, Y., Paxton, R. J., Hefta, L. J. F., and Shively, J. E. (1993) Cancer Res. 53, 1612-1619). We now show that the BGP promoter contains an interferon-sensitive response element (ISRE) that is specifically protected in in vivo footprints. Interferon regulatory factor-1 (IRF-1) was identified as the ISRE-binding factor by electrophoretic mobility shift assays. The induction of IRF-1 mRNA by IFN-γ in HT-29 cells reaches a maximum at 6 h and is superinduced by cycloheximide. Four mRNA species for BGP are induced by IFN-γ, the major band of which is inhibited by cycloheximide. Transfection of HT-29 cells with an IRF-1 expression plasmid (pAct-1) transactivates a BGP promoter reporter gene containing wild-type (but not mutant) ISRE. Electrophoretic mobility shift assay analysis of a second footprint reveals the binding of Sp1, an Sp1-like protein, and upstream stimulatory factor. The Sp1-like complex was also induced by IFN-γ treatment of HT-29 cells and may be a second point of transcriptional control for the BGP gene.

Footnotes

  • * This work was supported by National Institutes of Health Grants CA 37808 and CA 65767. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    BGP

    biliary glycoprotein

    CEA

    carcinoembryonic antigen

    IFN

    interferon

    GAS

    γ-interferon activation sequence

    IRF

    interferon regulatory factor

    ISRE

    interferon-stimulated response element

    USF

    upstream stimulatory factor

    PCR

    polymerase chain reaction

    LM-PCR

    ligation-mediated PCR

    EMSA

    electrophoretic mobility shift assay

    bp

    base pair

    GAPDH

    glyceraldehyde-3-phosphate dehydrogenase

    hGH

    human growth hormone

    IRE

    interferon-responsive element

    FP

    footprint

    DMS

    dimethyl sulfate

    HS

    hypersensitive site

    ISGF

    interferon-stimulated gene factor

    Stat

    signal transducers and activators of transcription.

    • Received June 17, 1996.
    • Revision received August 6, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement